Angiotensin-converting enzyme inhibi... [Nephrol Dial Transplant. 2003] - PubMed

Review Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis. [Curr Atheroscler Rep. 2002]
Review Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis.
Lonn E. Curr Atheroscler Rep. 2002 Sep; 4(5):363-72.
Analysis of factors causing hyperkalemia. [Intern Med. 2007]
Analysis of factors causing hyperkalemia.
Takaichi K, Takemoto F, Ubara Y, Mori Y. Intern Med. 2007; 46(12):823-9. Epub 2007 Jun 15.
Review Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events. [Am Heart J. 2009]
Review Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.
Papademetriou V. Am Heart J. 2009 Jun; 157(6 Suppl):S24-30.
Review Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy: its role in clinical practice. [J Clin Hypertens (Greenwich). 2003]
Review Combination angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy: its role in clinical practice.
Sica DA. J Clin Hypertens (Greenwich). 2003 Nov-Dec; 5(6):414-20.
Do we need yet another blocker of the renin-angiotensin system? [J Am Coll Cardiol. 2007]
Do we need yet another blocker of the renin-angiotensin system?
Messerli FH, Re RN. J Am Coll Cardiol. 2007 Mar 20; 49(11):1164-5. Epub 2007 Mar 6.

The positive predictive value of a hyperkalemia diagnosis in automated health care data. [Pharmacoepidemiol Drug Saf. 2010]
The positive predictive value of a hyperkalemia diagnosis in automated health care data.
Raebel MA, Smith ML, Saylor G, Wright LA, Cheetham C, Blanchette CM, Xu S. Pharmacoepidemiol Drug Saf. 2010 Nov; 19(11):1204-8.
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. [J Gen Intern Med. 2010]
Diabetes and drug-associated hyperkalemia: effect of potassium monitoring.
Raebel MA, Ross C, Xu S, Roblin DW, Cheetham C, Blanchette CM, Saylor G, Smith DH. J Gen Intern Med. 2010 Apr; 25(4):326-33. Epub 2010 Jan 20.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what...
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises.
Nephrol Dial Transplant. 2003 Oct ;18(10):1973-5.

PubMed
Primary pericardial mesothelioma.
Primary pericardial mesothelioma.
Curr Treat Options Oncol. 2002 Oct ;3(5):369-73.

PubMed
Effects of idebenone (CV-2619) on the concentrations of acetylcholine and cholin...
Effects of idebenone (CV-2619) on the concentrations of acetylcholine and choline in various brain regions of rats with cerebral ischemia.
Jpn J Pharmacol. 1984 Nov ;36(3):357-63.

PubMed
Effects of idebenone, a cerebral metabolism activator, on muricidal behavior in ...
Effects of idebenone, a cerebral metabolism activator, on muricidal behavior in rats with raphe lesions.
Pharmacol Biochem Behav. 1987 Jun ;27(2):351-3.

PubMed
Beneficial effect of idebenone (CV-2619) on cerebral ischemia-induced amnesia in...
Beneficial effect of idebenone (CV-2619) on cerebral ischemia-induced amnesia in rats.
Jpn J Pharmacol. 1984 Nov ;36(3):349-56.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed